Formulation and Evaluation of Extended Release Carbamazepine Matrix Tablets

被引:0
|
作者
Manivannan, R. [1 ]
Balasubramaniam, A. [1 ]
Sandeep, G. [1 ]
Afsal, V. T. Ibrahim [1 ]
机构
[1] JKK Munirajah Coll Pharm, Dept Pharmaceut, Ethirmedu 638183, Komarapalayam, India
关键词
Formulation; Extended release; Carbamazepine; DRUG-RELEASE; HPMC; VARIABLES;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of study was to prepare and characterize extended release matrix tablets of carbamazepine using hydrophilic polymers like HPMCK-100M, AVICEL PH-102 with or without HPMC K4M. Release kinetics evaluated by using USP-22 TYPE-I dissolution apparatus: The newly formulated extended release tablets of carbamazepine were compared with conventional marketed tablet. The in vitro drug release study revealed that HPMC K-100M formulation was able to sustain the drug release for 15 h (90.93 %). Fitting the in vitro drug release data to Koresmeyer equation indicated that diffusion along with erosion could be the mechanism of drug release. Further evaluation by DSC thermogram and FTIR studies conclude that no interaction between polymer And drug. The results suggest that the developed extended release tablets of carbamazepine could perform therapeutically equivalent to conventional dosage forms, leading to better patient compliance.
引用
收藏
页码:4737 / 4743
页数:7
相关论文
共 50 条
  • [11] FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF RANOLAZINE EXTENDED RELEASE TABLETS
    Saritha, Alladi
    Sanjana, Rebecca
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (01): : 682 - 687
  • [12] Formulation and evaluation of ranolazine extended release tablets: Influence of polymers
    Murthy, T. E. G. K.
    Mukkala, Bala Vishnu Priya
    Babu, Suresh V. V.
    ASIAN JOURNAL OF PHARMACEUTICS, 2011, 5 (03) : 162 - 166
  • [13] Formulation, Release Characteristics and Bioavailability Study of Oral Monolithic Matrix Tablets Containing Carbamazepine
    Nahla S. Barakat
    Ibrahim M. Elbagory
    Alanood S. Almurshedi
    AAPS PharmSciTech, 2008, 9 : 931 - 938
  • [14] Formulation, Release Characteristics and Bioavailability Study of Oral Monolithic Matrix Tablets Containing Carbamazepine
    Barakat, Nahla S.
    Elbagory, Ibrahim M.
    Almurshedi, Alanood S.
    AAPS PHARMSCITECH, 2008, 9 (03) : 931 - 938
  • [15] Formulation and Evaluation of Sustained Release Matrix Tablets of Quetiapine Fumarate
    Kumar, C. H. Praveen
    Reddy, M. Nalini Krishna
    Archana, Namany
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2015, 4 (04): : 244 - 248
  • [16] Formulation and evaluation of controlled release floating matrix tablets of Stavudine
    Vidyadhara, Suryadevara
    Nagendran, Irukulapati
    Sasidhar, Reddyvalam Lankapalli C.
    Devi, Vallabhaneni Akhila
    Swapna, Kadiyala
    ASIAN JOURNAL OF PHARMACEUTICS, 2012, 6 (04) : 259 - 265
  • [17] Formulation, evaluation and optimization of sustained release matrix tablets of captopril
    Pinank, V. Pandya
    Vandana, B. Patel
    Prajesh, Patel
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2012, 4 (05): : S77 - S78
  • [18] Formulation and Evaluation of Carbamazepine Fast Disintegrating Tablets
    Comoglu, Tansel
    PHARMAZEUTISCHE INDUSTRIE, 2010, 72 (01): : 150 - 158
  • [19] Formulation Development and Stability Studies of Norfloxacin Extended-Release Matrix Tablets
    Oliveira, Paulo Renato
    Mendes, Cassiana
    Klein, Lilian
    Sangoi, Maximiliano da Silva
    Bernardi, Larissa Sakis
    Segatto Silva, Marcos Antonio
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [20] INFLUENCE OF SOME FORMULATION FACTORS ON THE RELEASE OF FELODIPINE FROM EXTENDED RELEASE HYDROPHILIC MATRIX TABLETS
    Iovanov, Rares I.
    Tomuta, Ioan
    Leucuta, Sorin E.
    FARMACIA, 2009, 57 (05) : 582 - 589